Attached files
| file | filename |
|---|---|
| EX-23.2 - EX-23.2 CONSENT OF EY - Apellis Pharmaceuticals, Inc. | apls-ex232_12.htm |
| EX-32.2 - EX-32.2 - Apellis Pharmaceuticals, Inc. | apls-ex322_9.htm |
| EX-32.1 - EX-32.1 - Apellis Pharmaceuticals, Inc. | apls-ex321_13.htm |
| EX-31.2 - EX-31.2 - Apellis Pharmaceuticals, Inc. | apls-ex312_6.htm |
| EX-31.1 - EX-31.1 - Apellis Pharmaceuticals, Inc. | apls-ex311_11.htm |
| EX-23.1 - EX-23.1 - Apellis Pharmaceuticals, Inc. | apls-ex231_8.htm |
| EX-10.26 - EX-10.26 - Apellis Pharmaceuticals, Inc. | apls-ex1026_87.htm |
| EX-10.25 - EX-10.25 - Apellis Pharmaceuticals, Inc. | apls-ex1025_88.htm |
| EX-10.17 - EX-10.17 - Apellis Pharmaceuticals, Inc. | apls-ex1017_217.htm |
| EX-4.4 - EX-4.4 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE SECURITIES E - Apellis Pharmaceuticals, Inc. | apls-ex44_10.htm |
| 10-K - 10-K - Apellis Pharmaceuticals, Inc. | apls-10k_20201231.htm |
Exhibit 21.1
SUBSIDIARIES OF APELLIS PHARMACEUTICALS, INC.
|
|
|
|
|
Subsidiary |
|
Jurisdiction of Incorporation or Organization |
|
Apellis Australia Pty Ltd. |
|
Australia |
|
Apellis Bermuda Ltd |
|
Bermuda |
|
APL DEL Holdings LLC |
|
United States |
|
Apellis Germany GmbH |
|
Germany |
|
Apellis Ireland Ltd. |
|
Ireland |
|
Apellis Netherlands, B.V. |
|
Netherlands |
|
Apellis Switzerland GmbH |
|
Switzerland |
|
Apellis U.K. Limited |
|
United Kingdom |
|
Apellis MA Securities Inc. |
|
United States |
|
APL Sales I, LLC |
|
United States |
|
APL PRG I, Corp. |
|
United States |